Top Markets
Coin of the day
Shenzhen Salubris Pharmaceuticals Co., Ltd. Shenzhen Salubris Pharmaceuticals Co., Ltd.

Shenzhen Salubris Pharmaceuticals Co., Ltd.

002294
Classement en actions #3529
Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris... Established in 1998 and headquartered in Shenzhen, China, Shenzhen Salubris Pharmaceuticals Co., Ltd. operates across the entire pharmaceutical value chain, from research and development to manufacturing and sales. The company primarily focuses on critical therapeutic areas within China, including cardiovascular, anti-diabetic, anti-cancer, and orthopedic medicine. Its diverse product portfolio features a variety of cardiovascular and cerebrovascular medications, such as allisartan isoproxil and clopidogrel bisulfate tablets, alongside injectable options like bivalirudin. A significant offering is the recombinant SeV-hFGF2/dF Injection, specifically developed for the treatment of diabetic foot disease. Salubris also manufactures anti-tumor and orthopedic drugs. Furthermore, its anti-infective range encompasses numerous injectable antibiotics, including ceftazidime and ceftriaxone sodium, as well as oral preparations such as azithromycin dispersible and levetiracetam tablets. The firm also innovates in biotechnological drugs, developing recombinant proteins and monoclonal antibodies. Complementing its domestic operations, Shenzhen Salubris Pharmaceuticals engages in the import, in-licensing, and out-licensing of medicines, particularly for European markets.
Prix de l'action
$4.64
Capitalisation boursière
$5.18B
Changement (1 jour)
0.38%
Changement (1 an)
-37.44%
Pays
CN
Échange Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)

Catégorie

Historique du prix de l'action pour Shenzhen Salubris Pharmaceuticals Co., Ltd. (002294)
Prix de clôture le plus élevé : $4.97 le 2026-08-01

Prix de clôture le plus bas : $1.19 le 2009-09-01
Historique du prix de l'action de Shenzhen Salubris Pharmaceuticals Co., Ltd. de 2009 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) -13.99%
2025 80.15%
2024 -0.06%
2023 -1.96%
2022 6.35%
2021 1.19%
2020 61.60%
2019 -18.68%
2018 -47.95%
2017 49.36%
2016 -11.86%
2015 30.44%
2014 5.05%
2013 45.58%
2012 57.04%
2011 -36.22%
2010 64.27%
2009 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$371.13 -21.75%
US
$188.78 -39.02%
FR
$162.88 24.70%
JP
$189.94 24.49%
US
$76.37 -5.96%
CH